p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2

Cancer Research

Volumn 61, Issue 7, 2001, Pages 2816-2821

  Esteller, Manel ^a,b   Cordon Cardo, Carlos ^c   Corn, Paul G ^a   Meltzer, Steve J ^d   Pohar, Kamal S ^c   Watkins, D Neil ^a   Capella, Gabriel ^e   Peinado, Miguel Angel ^e   Matias Guiu, Xavier ^f   Prat, Jaime ^f   Baylin, Stephen B ^a   Herman, James G ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Hospital Infantil Universitario Niño Jesús   (Spain)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e HOSPITAL DURAN I REYNALS   (Spain)

^f HOSPITAL SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MDM2 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN; PROTEIN MDM2; PROTEIN P14ARF; 5 AZA 2' DEOXYCYTIDINE; GENE PRODUCT; PROTEIN P14; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; DNA METHYLATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PROMOTER REGION; PROTEIN SYNTHESIS; CELL TRANSPORT; CELL TYPE; CELLULAR DISTRIBUTION; COLORECTAL CANCER; CONTROLLED STUDY; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; GENE INACTIVATION; GENE LOCUS; GLIOMA; HUMAN CELL; KIDNEY CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN METHYLATION; STOMACH CANCER; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0035297539     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Signaling to p53: Breaking the MDM2-p53 circuit
2. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
3. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
4. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
5. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
6. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
7. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
8. p19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2
9. Nucleolar Arf sequesters Mdm2 and activates p53
10. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53
11. Hypermethylation of tumor suppressor genes in cancer
12. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics
13. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and downregulated by wild-type p53
14. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status
15. Alterations and hypermethylation of the p14(ARF) gene in gastric cancer
16. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer
17. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis
18. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
19. Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications
20. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
21. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies
22. Interaction between the retinoblastoma protein and the oncoprotein MDM2
23. RB regulates the stability and the apoptotic function of p53 via MDM2
24. Tumor suveillance via the ARF-p53 pathway
25. The INK4A/ARF locus and its two gene products
26. The Pezcoller lecture: Cancer cell cycles revisited
27. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
28. Immunolocalization of human p14(ARF) to the granular component of the interphase nucleolus
29. Identification of a cryptic nucleolar-localization signal in MDM2
30. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function
31. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer
32. Opposing effects of Ras on p53: Transcriptional activation of mdm2 and induction of p19ARF
33. The p53-mdm-2 autoregulatory feedback loop
34. Generation of oscillations by the p53-mdm2 feedback loop: A theoretical and experimental study